ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00811135
Brief Title: A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer

First Submitted : December 16, 2008
First Submitted that Met QC Criteria : December 17, 2008
First Posted : December 18, 2008 (Estimate)

Results First Submitted : November 3, 2015
Results First Submitted that Met QC Criteria : November 3, 2015
Results First Posted : December 8, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : August 23, 2016
Last Update Posted : September 29, 2016 (Estimate)